22-31804863-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001242896.3(DEPDC5):​c.1165C>T​(p.Arg389Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0288 in 1,613,738 control chromosomes in the GnomAD database, including 765 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R389H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.019 ( 41 hom., cov: 32)
Exomes 𝑓: 0.030 ( 724 hom. )

Consequence

DEPDC5
NM_001242896.3 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.00

Publications

14 publications found
Variant links:
Genes affected
DEPDC5 (HGNC:18423): (DEP domain containing 5, GATOR1 subcomplex subunit) This gene encodes a member of the IML1 family of proteins involved in G-protein signaling pathways. The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates cell growth by sensing the availability of nutrients. The protein encoded by this gene is a component of the GATOR1 (GAP activity toward Rags) complex which inhibits the amino acid-sensing branch of the mTORC1 pathway. Mutations in this gene are associated with autosomal dominant familial focal epilepsy with variable foci. A single nucleotide polymorphism in an intron of this gene has been associated with an increased risk of hepatocellular carcinoma in individuals with chronic hepatitis C virus infection. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
DEPDC5 Gene-Disease associations (from GenCC):
  • epilepsy, familial focal, with variable foci 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, Illumina, G2P
  • focal epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant epilepsy with auditory features
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial focal epilepsy with variable foci
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Brugada syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0044102967).
BP6
Variant 22-31804863-C-T is Benign according to our data. Variant chr22-31804863-C-T is described in ClinVar as Benign. ClinVar VariationId is 238672.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0194 (2956/152276) while in subpopulation NFE AF = 0.032 (2177/68012). AF 95% confidence interval is 0.0309. There are 41 homozygotes in GnomAd4. There are 1354 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2956 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DEPDC5NM_001242896.3 linkc.1165C>T p.Arg389Cys missense_variant Exon 17 of 43 ENST00000651528.2 NP_001229825.1 O75140-10

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DEPDC5ENST00000651528.2 linkc.1165C>T p.Arg389Cys missense_variant Exon 17 of 43 NM_001242896.3 ENSP00000498382.1 O75140-10
ENSG00000285404ENST00000646701.1 linkc.1081C>T p.Arg361Cys missense_variant Exon 15 of 21 ENSP00000496158.1 A0A2R8YF50

Frequencies

GnomAD3 genomes
AF:
0.0194
AC:
2956
AN:
152158
Hom.:
41
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00574
Gnomad AMI
AF:
0.0318
Gnomad AMR
AF:
0.0153
Gnomad ASJ
AF:
0.00778
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0110
Gnomad FIN
AF:
0.0163
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0320
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.0221
AC:
5519
AN:
249426
AF XY:
0.0218
show subpopulations
Gnomad AFR exome
AF:
0.00426
Gnomad AMR exome
AF:
0.0257
Gnomad ASJ exome
AF:
0.0111
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0200
Gnomad NFE exome
AF:
0.0306
Gnomad OTH exome
AF:
0.0223
GnomAD4 exome
AF:
0.0298
AC:
43568
AN:
1461462
Hom.:
724
Cov.:
30
AF XY:
0.0294
AC XY:
21366
AN XY:
727040
show subpopulations
African (AFR)
AF:
0.00463
AC:
155
AN:
33472
American (AMR)
AF:
0.0245
AC:
1094
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.0121
AC:
315
AN:
26124
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39686
South Asian (SAS)
AF:
0.0148
AC:
1273
AN:
86232
European-Finnish (FIN)
AF:
0.0208
AC:
1113
AN:
53406
Middle Eastern (MID)
AF:
0.00954
AC:
55
AN:
5768
European-Non Finnish (NFE)
AF:
0.0342
AC:
37992
AN:
1111694
Other (OTH)
AF:
0.0260
AC:
1570
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
2117
4234
6351
8468
10585
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1430
2860
4290
5720
7150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0194
AC:
2956
AN:
152276
Hom.:
41
Cov.:
32
AF XY:
0.0182
AC XY:
1354
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.00573
AC:
238
AN:
41550
American (AMR)
AF:
0.0153
AC:
234
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00778
AC:
27
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.0110
AC:
53
AN:
4822
European-Finnish (FIN)
AF:
0.0163
AC:
173
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0320
AC:
2177
AN:
68012
Other (OTH)
AF:
0.0114
AC:
24
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
148
295
443
590
738
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0272
Hom.:
238
Bravo
AF:
0.0195
TwinsUK
AF:
0.0353
AC:
131
ALSPAC
AF:
0.0343
AC:
132
ESP6500AA
AF:
0.00634
AC:
24
ESP6500EA
AF:
0.0350
AC:
289
ExAC
AF:
0.0226
AC:
2729
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.0294
EpiControl
AF:
0.0276

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 29, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 23, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Mar 14, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Familial focal epilepsy with variable foci Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.021
.;.;.;.;.;.;.;.;T;.;.;.;.;.;.;T;.;.;.;.;.;.
Eigen
Benign
-0.38
Eigen_PC
Benign
-0.42
FATHMM_MKL
Benign
0.63
D
LIST_S2
Uncertain
0.94
D;D;D;D;D;D;D;D;D;D;.;.;D;D;.;.;D;D;.;D;D;D
MetaRNN
Benign
0.0044
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L;.;.;L;L;.;.;L;L;.;L;.;L;.;L;L;.;.;L;L;.;.
PhyloP100
1.0
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-0.69
N;.;.;.;.;.;.;.;N;.;N;.;.;.;N;N;.;.;N;N;.;.
REVEL
Benign
0.052
Sift
Benign
0.16
T;.;.;.;.;.;.;.;T;.;T;.;.;.;T;T;.;.;T;T;.;.
Sift4G
Benign
0.18
T;.;.;.;.;.;.;.;T;.;T;.;.;.;T;T;.;.;T;T;.;.
Polyphen
0.90, 0.88
.;.;.;.;.;.;.;P;P;.;.;.;.;.;P;P;.;.;.;.;.;.
Vest4
0.16
MPC
0.54
ClinPred
0.013
T
GERP RS
-0.89
Varity_R
0.053
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41311139; hg19: chr22-32200849; COSMIC: COSV56691655; API